Finding 1175188 (2025-001)

Material Weakness Repeat Finding
Requirement
B
Questioned Costs
-
Year
2025
Accepted
2026-02-24

AI Summary

  • Core Issue: Missing documentation for three cash disbursements raises concerns about compliance with internal controls.
  • Impacted Requirements: Lack of proper documentation may lead to noncompliance with federal program requirements.
  • Recommended Follow-Up: Implement an additional review process by knowledgeable staff to ensure proper oversight and documentation retention.

Finding Text

Criteria : Cash disbursements should be approved and reviewed as per the internal controls in place in the organization and the related documentation should be retained. Condition : No supporting documentation could be located for three of the expenses selected for testing. Cause : Organization not maintaining the proper documentation due to transition in accounting staff/management. Effect : No proper documentation may result in the expenditures of federal program not being properly monitored, thus resulting in potential noncompliance with program requirements. Recommendation : We recommend management implement an additional/alternate level of review by someone with proper knowledge to oversee the disbursements made under the program and the documentation is retained properly. Management’s Response : See Management’s View and Corrective Action Plan included at the end of the report.

Corrective Action Plan

Information on the Federal Program : ALN – 93.399 – Cancer Control Research Criteria : Cash disbursements should be approved and reviewed as per the internal controls in place in the organization and the related documentation should be retained. Condition : No supporting documentation could be located for three of the expenses selected for testing. Management’s Response : Columbus NCORP will retrain all support for cash disbursements moving forward. Anticipated Completion Date: January 31, 2026

Categories

Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1175189 2025-002
    Material Weakness Repeat
  • 1175190 2025-003
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.399 CANCER CONTROL $1.01M